Fundraising Fox

Biobot Analytics

YC W18

Boston, US · Founded 2017 · Delaware corporation · 12 employees · 12 known investors

Biobot pioneers wastewater epidemiology, monitoring pathogens and substances in sewage to provide real-time public health surveillance at the community level. The company serves public health agencies, vaccine manufacturers, and hospital systems globally.

BiotechData & InfrastructureGovTechHealthtechHealth TechAnalyticsUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W18)

Biobot Analytics was founded in 2017 by Newsha Ghaeli, Mariana Matus, and Mariana Guadalupe Matus Garcia.

NGNewsha Ghaeli
Newsha GhaeliinPresident & Cofounder
MMMariana Matus
Mariana Matusin𝕏CEO and Cofounder
MG
Mariana Guadalupe Matus GarciaCo-founder

Board

VPVivek Pattipati
Vivek PattipatiinBoard directorPartner at Valor Equity Partners
APAndrew Perlman
Andrew PerlmaninBoard directorManaging Partner at GreatPoint Ventures

Investors · 12

Reported raises · per SEC filings

Form D private placements

$41M disclosed across 3 rounds · 2020–2025

$13.5MraisedJun 2025 · 46 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Vivek PattipatiDirector
  • Newsha GhaeliExecutive Officer, Director
  • Andrew PerlmanDirector
  • Mariana Guadalupe Matus GarciaExecutive Officer, Director
Offering amount
$13.6M
Amount sold
$13.5M
First sale
May 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$20.8MraisedNov 2021 · 26 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Mariana Guadalupe Matus GarciaExecutive Officer, Director
  • Rich-Henry SchabowskyDirector
  • Newsha GhaeliExecutive Officer, Director
  • Ann DeWittDirector
Offering amount
$20.8M
Amount sold
$20.8M
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6.7MraisedApr 2020 · 29 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Newsha GhaeliExecutive Officer, Director
  • Mariana Guadalupe Matus GarciaExecutive Officer, Director
Offering amount
$6.7M
Amount sold
$6.7M
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$1.3M
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$212.3K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Biobot Analytics do?
Biobot pioneers wastewater epidemiology, monitoring pathogens and substances in sewage to provide real-time public health surveillance at the community level. The company serves public health agencies, vaccine manufacturers, and hospital systems globally.
Who founded Biobot Analytics?
Biobot Analytics was founded by Newsha Ghaeli, Mariana Matus, Mariana Guadalupe Matus Garcia in 2017.
Who are Biobot Analytics's investors?
Biobot Analytics's investors include American Family Insurance Institute for Corporate and Social Impact, Blindspot Ventures Management Co, DCVC (Data Collective), Dorm Room, Homebrew, Pathbreaker Ventures, Plum Alley Investments, The Engine Ventures and 4 more.
How much funding has Biobot Analytics raised?
Biobot Analytics has disclosed $41M raised across 3 rounds.
Where is Biobot Analytics headquartered?
Biobot Analytics is headquartered in Boston, US.